MarketKrystal Biotech And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Oct 6, 2024
MarketSarepta Therapeutics And 5 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Sep 20, 2024
MarketSarepta Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Sep 4, 2024
MarketRedwood Trust And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Aug 31, 2024
MarketSarepta Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Aug 25, 2024
MarketSangamo Therapeutics And FibroGen On The List Of Winners And Losers Of Tuesday's US SessionViaNews Editorial Team•Feb 20, 2024
MarketSarepta Therapeutics And Novavax On The List Of Winners And Losers Of Wednesday's US SessionViaNews Editorial Team•Mar 1, 2023
